FIELD: biotechnology.
SUBSTANCE: present invention relates to the field of biotechnology, in particular to new saccharides, and can be applied in medical practice.
EFFECT: invention discloses a modified O-polysaccharide capable of stimulating an immune response in a mammal against pathogenic E. coli serotypes.
25 cl, 25 dwg, 21 tbl, 23 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ESCHERICHIA COLI COMPOSITIONS AND METHODS BASED THEREON | 2021 |
|
RU2821929C1 |
| PURIFICATION OF SACCHARIDES | 2021 |
|
RU2816593C1 |
| INCREASE IN IMMUNOGENICITY OF STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES | 2018 |
|
RU2774891C2 |
| NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS FOR USING THEM | 2017 |
|
RU2739504C2 |
| COMPOSITIONS OF IMMUNOGENIC/THERAPEUTIC GLYCOCONJUGATES AND USE THEREOF | 2015 |
|
RU2720295C2 |
| IGG4 Fc FRAGMENT CONTAINING A MODIFIED HINGE REGION | 2014 |
|
RU2800558C1 |
| IMMUNOGENIC FUSED PROTEIN | 2016 |
|
RU2757426C2 |
| GBO-ACTRIIB RECOMBINANT PROTEIN FOR INCREASING MUSCLE MASS IN FARM ANIMALS AND POULTRY | 2022 |
|
RU2792817C1 |
| MULTIMERIZING POLYPEPTIDES DERIVED FROM DOMAIN WITH ROLL-TYPE PENTONE BASE OF ADENOVIRUS | 2019 |
|
RU2820522C2 |
| RECOVERED ANTIBODY (VERSIONS), A METHOD FOR PRODUCING THE ANTIBODY, AN ISOLATED NUCLEIC ACID, AN EXPRESSION CASSETTE (VERSIONS), A PLASMID (VERSIONS), A HOST CELL, A PHARMACEUTICAL PREPARATION, A KIT, A METHOD OF TREATING A PATIENT, AT RISK OF OR SUFFERING FROM ESCHERICHIA COLI INFECTION, AND A DIAGNOSTIC TECHNIQUE FOR DETERMINING ESCHERICHIA COLI INFECTIONS | 2014 |
|
RU2724530C2 |
